ArticleFrontiers in oncology2023

Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial.

C F Stockem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.